Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate
Key result
The cost utility method of ranking treatments used by development and evaluation committees may lead to poor decision making due to strong assumptions and selective use of evidence.
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
The appraisal process for new drugs by NICE, mirroring regional development and evaluation committees, may be inadequate due to inappropriate cost utility methods.
PICO
E
Exposure / Comparator
Cost utility method for drug appraisal
The appraisal process for new drugs by NICE, mirroring regional development and evaluation committees, may be inadequate due to inappropriate cost utility methods.
Cite This Study
Freemantle et al. (1999) reported an editorial. Cost utility method for drug appraisal was evaluated. The cost utility method of ranking treatments used by development and evaluation committees may lead to poor decision making due to strong assumptions and selective use of evidence.